# Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome

Study · id `cardio:ct-nct04873934` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04873934](<https://clinicaltrials.gov/study/NCT04873934>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04873934

Browse, organ or system: Heart; Blood vessels; Metabolism  
Browse, condition area: Risk and prevention; Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 400 participants.

## Technical summary

Registry record NCT04873934. Randomized; no masking; primary purpose treatment. Start 2021-06-24 (actual); primary completion 2024-08-07 (actual). Results posted on 2025-08-21.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 400 participants (enrolled count; ClinicalTrials.gov record NCT04873934, source copy `cardio:ctgov-nct04873934-2025-10-16`, retrieved 2026-10-31)
- Started: 2021-06-24 (actual) (ClinicalTrials.gov record NCT04873934, source copy `cardio:ctgov-nct04873934-2025-10-16`, retrieved 2026-10-31)
- Primary completion: 2024-08-07 (actual) (ClinicalTrials.gov record NCT04873934, source copy `cardio:ctgov-nct04873934-2025-10-16`, retrieved 2026-10-31)
- Completion: 2024-08-07 (actual) (ClinicalTrials.gov record NCT04873934, source copy `cardio:ctgov-nct04873934-2025-10-16`, retrieved 2026-10-31)
- Results first posted: 2025-08-21 (ClinicalTrials.gov record NCT04873934, source copy `cardio:ctgov-nct04873934-2025-10-16`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT04873934, source copy `cardio:ctgov-nct04873934-2025-10-16`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04873934-2025-10-16`, retrieved 2026-10-31)

## The registry's words

- Brief title: Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome
- Acronym: V-INCEPTION
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Inclisiran
- Lead sponsor: Novartis Pharmaceuticals
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry intervention name matches this record: Inclisiran (`cardio:inclisiran`)
- Registry lists this organization as the lead sponsor: Novartis (`cardio:novartis`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Low-Density Lipoprotein Cholesterol Lowering With Inclisiran Plus Usual Care in Recent Acute Coronary Syndrome: VICTORION-INCEPTION, a Randomized, Controlled, Open-Label Trial (`cardio:pubmed-42132192`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: cb7d789e49ac22da442c88ee1999017a749d63879b7964d713b81ce38a5f6aa0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
